{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T21:42:54Z","timestamp":1787694174284,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.vaccine.2004.03.037","type":"journal-article","created":{"date-parts":[[2004,4,24]],"date-time":"2004-04-24T09:18:25Z","timestamp":1082798305000},"page":"3649-3657","source":"Crossref","is-referenced-by-count":21,"title":["10\u201312 years follow-up of highly bacillated BL\/LL leprosy patients on combined chemotherapy and immunotherapy"],"prefix":"10.1016","volume":"22","author":[{"given":"Kiran","family":"Katoch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwa Mohan","family":"Katoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Natrajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Sreevatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh Dutt","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnu Dutt","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Channappa T","family":"Shivanavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.03.037_BIB1","unstructured":"WHO Expert Committee on Leprosy. Sixth Report. WHO Tech Rep Ser 768. Geneva: World Health Organization; 1988."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB2","unstructured":"World Health Organization. Progress towards elimination of leprosy as a public health problem, Weekly Epidemiol Rec 1993; 68: 181\u201388."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB3","unstructured":"WHO Expert Committee on Leprosy. Seventh report. WHO Tech Rep Ser No 874. Geneva: World Health Organization; 1998."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB4","first-page":"195","article-title":"Relapse rate after long term follow up of multibacillary patients treated by WHO multidrug regimen","volume":"63","author":"Jamet","year":"1995","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB5","first-page":"223","article-title":"Recent developments in the field of multidrug therapy and future research in chemotherapy of leprosy","volume":"57","author":"Grosset","year":"1986","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB6","first-page":"372","article-title":"A comparison of low and conventional dosage of Dapsone in treatment of lepromatous leprosy","volume":"49","author":"Iyer","year":"1977","journal-title":"Lepr. India"},{"key":"10.1016\/j.vaccine.2004.03.037_BIB7","first-page":"157","article-title":"A modified method of harvesting M. leprae from the foot pads of mice","volume":"48","author":"Desikan","year":"1976","journal-title":"Lepr. India"},{"key":"10.1016\/j.vaccine.2004.03.037_BIB8","first-page":"615","article-title":"Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological Index, and FDA-EB staining","volume":"57","author":"Katoch","year":"1989","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB9","first-page":"451","article-title":"Results of a modified WHO regimen in highly bacilliferous BL\/LL patients","volume":"57","author":"Katoch","year":"1989","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB10","first-page":"202","article-title":"Treatment of bacilliferrous BL\/LL cases with combined chemotherapy and immunotherapy","volume":"63","author":"Katoch","year":"1995","journal-title":"Int. J. Lepr."},{"issue":"2","key":"10.1016\/j.vaccine.2004.03.037_BIB11","first-page":"79","article-title":"Histological changes in combined chemotherapy and immunotherapy in highly bacillated lepromatous leprosy","volume":"8","author":"Natrajan","year":"1992","journal-title":"Acta Leprol."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0264-410X(90)90002-4","article-title":"Mycobacterium vaccae in the immunoprophylaxis and immunotherapy of leprosy and tuberculosis","volume":"8","author":"Stanford","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.037_BIB13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/infdis\/167.2.401","article-title":"Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy","volume":"167","author":"Zaheer","year":"1993","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB14","first-page":"821","article-title":"Elimination of Mycobacterium leprae by other mycobacteria","volume":"17","author":"Convit","year":"1974","journal-title":"Clin. Exp. Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.037_BIB15","first-page":"179","article-title":"Mycobacterium w vaccine, a useful adjuvant to multidrug therapy in multibacillary leprosy a report on hospital-based immunotherapeutic clinical trials with a follow-up of 1\u20137 years after treatment","volume":"71","author":"Sharma","year":"2000","journal-title":"Lepr. Rev."},{"issue":"3","key":"10.1016\/j.vaccine.2004.03.037_BIB16","first-page":"187","article-title":"Impact of combined mycobacterium w vaccine and 1 year of MDT on multibacillary leprosy patients","volume":"60","author":"Sarkar","year":"2001","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB17","first-page":"219","article-title":"Reversal reactions in multibacillary leprosy patients following MDT with and without immunotherapy with a candidate anti-leprosy vaccine Mycobacterium w","volume":"64","author":"Kar","year":"1993","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB18","first-page":"358","article-title":"The immunotherapeutic potential of ICRC vaccine\u2014a case-controlled study","volume":"63","author":"Bhatki","year":"1992","journal-title":"Lepr. Rev."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.173.4.993","article-title":"The systemic effect of recombinant interleukin-2 on the manifestations of lepromatous leprosy","volume":"173","author":"Kaplan","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB20","unstructured":"Fernandez JMM. Use of BCG in immunoprophylaxis of leprosy. Rev Arg Dermatol 1939;23:425."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB21","first-page":"415","article-title":"Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda negative contacts","volume":"50","author":"Convit","year":"1982","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB22","first-page":"302","article-title":"Histological responses in sixty multibacillary leprosy patients inoculated with autoclaved Mycobacterium leprae and live BCG","volume":"56","author":"Meyer","year":"1988","journal-title":"Int. J. Lepr."},{"issue":"1","key":"10.1016\/j.vaccine.2004.03.037_BIB23","first-page":"153","article-title":"Immunotherapy of treated BL\/LL cases with BCG: histological, immunohistological and bacteriological assessment","volume":"7","author":"Katoch","year":"1989","journal-title":"Acta Leprol."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB24","first-page":"28","article-title":"Histopathological monitoring of an immunotherapeutic trial with Mycobacterium w","volume":"60","author":"Mukherjee","year":"1992","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB25","doi-asserted-by":"crossref","unstructured":"Hasting RC, Job CK. Reversal reaction in lepromatous leprosy following transfer factor therapy. Am J Trop Med Hyg 1978;27:995\u20131004.","DOI":"10.4269\/ajtmh.1978.27.995"},{"key":"10.1016\/j.vaccine.2004.03.037_BIB26","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.173.4.993","article-title":"The systemic effect of recombinant interleukin-2 on the manifestations of lepromatous leprosy","volume":"173","author":"Kaplan","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB27","first-page":"98","article-title":"Long term follow-up of lepromatous leprosy patients receiving intralesional recombinant gamma interferon","volume":"60","author":"Mathur","year":"1992","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB28","unstructured":"Subcommittee on clinical trials of scientific working group on chemotherapy of leprosy (THELEP) of UNDP\/World Bank\/WHO special programme for research in tropical diseases. THELEP controlled clinical drug trials, Int J Lepr 1987; 55 (Suppl): 864\u201368."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB29","unstructured":"Sreevatsa, Girdhar BK, Desikan KV, Screening of drug resistant strains of Mycobacterium lepraein lepromatous leprosy patients under moltidrug therapy, Indian J Med Res 1988; 87: 139\u2013143."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB30","first-page":"161","article-title":"Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy programme of the All Africa Leprosy and Rehabilitation Training Centre (ALERT), Ethopia","volume":"60","author":"Becx-Bleumink","year":"1992","journal-title":"Int. J. Lepr."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB31","unstructured":"WHO leprosy unit. Risk of relapse in leprosy. WHO document. WHO\/CTD\/Lep\/94.1."},{"key":"10.1016\/j.vaccine.2004.03.037_BIB32","unstructured":"Marchoux Chemotherapy Study Group. Relapse rates in multibacillary leprosy patients after stopping treatment with Rifampicin containing combined regimens, Int J Lepr 1992; 60: 525\u201335."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T07:25:51Z","timestamp":1549783551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":32,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0264410X04002853"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.03.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}